Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Melatonin secretion and the incidence of type 2 diabetes.

McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP.

JAMA. 2013 Apr 3;309(13):1388-96. doi: 10.1001/jama.2013.2710.

2.

A nested case-control study of the association between melatonin secretion and incident myocardial infarction.

McMullan CJ, Rimm EB, Schernhammer ES, Forman JP.

Heart. 2017 May;103(9):694-701. doi: 10.1136/heartjnl-2016-310098. Epub 2016 Nov 2.

PMID:
27806988
3.

Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women.

McMullan CJ, Curhan GC, Schernhammer ES, Forman JP.

Am J Epidemiol. 2013 Jul 15;178(2):231-8. doi: 10.1093/aje/kws470. Epub 2013 Jun 28.

4.

Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes.

Reutrakul S, Siwasaranond N, Nimitphong H, Saetung S, Chirakalwasan N, Chailurkit LO, Srijaruskul K, Ongphiphadhanakul B, Thakkinstian A.

Chronobiol Int. 2017;34(3):382-392. doi: 10.1080/07420528.2016.1278382. Epub 2017 Jan 27.

PMID:
28128991
5.

Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.

Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Sieri S, Sempos CT, Cavalleri A, Sch√ľnemann HJ, Strano S, Muti P.

J Natl Cancer Inst. 2008 Jun 18;100(12):898-905. doi: 10.1093/jnci/djn171. Epub 2008 Jun 10.

6.

Melatonin and breast cancer: a prospective study.

Travis RC, Allen DS, Fentiman IS, Key TJ.

J Natl Cancer Inst. 2004 Mar 17;96(6):475-82.

PMID:
15026473
7.

First-morning urinary melatonin and breast cancer risk in the Guernsey Study.

Wang XS, Tipper S, Appleby PN, Allen NE, Key TJ, Travis RC.

Am J Epidemiol. 2014 Mar 1;179(5):584-93. doi: 10.1093/aje/kwt302. Epub 2014 Jan 12.

8.

Urinary melatonin and risk of ovarian cancer.

Poole EM, Schernhammer E, Mills L, Hankinson SE, Tworoger SS.

Cancer Causes Control. 2015 Oct;26(10):1501-6. doi: 10.1007/s10552-015-0640-2. Epub 2015 Jul 30.

9.

Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort.

Obayashi K, Saeki K, Kurumatani N.

J Urol. 2014 Jun;191(6):1816-21. doi: 10.1016/j.juro.2013.12.043. Epub 2013 Dec 30.

PMID:
24384156
10.

Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II.

Brown SB, Hankinson SE, Eliassen AH, Reeves KW, Qian J, Arcaro KF, Wegrzyn LR, Willett WC, Schernhammer ES.

Am J Epidemiol. 2015 Feb 1;181(3):155-62. doi: 10.1093/aje/kwu261. Epub 2015 Jan 13.

11.

Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort.

Sturgeon SR, Doherty A, Reeves KW, Bigelow C, Stanczyk FZ, Ockene JK, Liu S, Manson JE, Neuhouser ML.

Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):629-37. doi: 10.1158/1055-9965.EPI-13-1028. Epub 2014 Feb 7.

12.

Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore.

Wu AH, Stanczyk FZ, Wang R, Koh WP, Yuan JM, Yu MC.

Int J Cancer. 2013 Feb 15;132(4):891-6. doi: 10.1002/ijc.27653. Epub 2012 Jun 28.

13.

Association between urinary 6-sulfatoxymelatonin excretion and arterial stiffness in the general elderly population: the HEIJO-KYO cohort.

Obayashi K, Saeki K, Kurumatani N.

J Clin Endocrinol Metab. 2014 Sep;99(9):3233-9. doi: 10.1210/jc.2014-1262. Epub 2014 May 30.

PMID:
24878050
14.

Positive effect of daylight exposure on nocturnal urinary melatonin excretion in the elderly: a cross-sectional analysis of the HEIJO-KYO study.

Obayashi K, Saeki K, Iwamoto J, Okamoto N, Tomioka K, Nezu S, Ikada Y, Kurumatani N.

J Clin Endocrinol Metab. 2012 Nov;97(11):4166-73. doi: 10.1210/jc.2012-1873. Epub 2012 Sep 4.

PMID:
22948764
15.

Dietary pattern, inflammation, and incidence of type 2 diabetes in women.

Schulze MB, Hoffmann K, Manson JE, Willett WC, Meigs JB, Weikert C, Heidemann C, Colditz GA, Hu FB.

Am J Clin Nutr. 2005 Sep;82(3):675-84; quiz 714-5.

16.

Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort.

Schernhammer ES, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):74-9. doi: 10.1158/1055-9965.EPI-08-0637.

17.

Urinary melatonin levels and breast cancer risk.

Schernhammer ES, Hankinson SE.

J Natl Cancer Inst. 2005 Jul 20;97(14):1084-7.

PMID:
16030307
18.

Melatonin Secretion and Muscle Strength in Elderly Individuals: A Cross-Sectional Study of the HEIJO-KYO Cohort.

Obayashi K, Saeki K, Maegawa T, Iwamoto J, Sakai T, Otaki N, Kataoka H, Kurumatani N.

J Gerontol A Biol Sci Med Sci. 2016 Sep;71(9):1235-40. doi: 10.1093/gerona/glw030. Epub 2016 Mar 1.

PMID:
26933161
19.

Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses' Health Study cohorts.

Schernhammer ES, Feskanich D, Niu C, Dopfel R, Holmes MD, Hankinson SE.

Am J Clin Nutr. 2009 Oct;90(4):975-85. doi: 10.3945/ajcn.2009.27826. Epub 2009 Aug 12.

20.

Urinary melatonin and risk of incident hypertension among young women.

Forman JP, Curhan GC, Schernhammer ES.

J Hypertens. 2010 Mar;28(3):446-51. doi: 10.1097/HJH.0b013e3283340c16.

Supplemental Content

Support Center